Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Does the Projected Growth of the Iron Deficiency Anemia Market Compare Over the Forecast Period?
The market size for iron deficiency anemia has experienced significant growth in the previous years. This market is projected to expand from $3.37 billion in 2024 to $3.58 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. The growth seen in the historic period can be linked to factors such as efforts from non-governmental organizations, an escalation in the instances of chronic diseases, greater emphasis on parental care, campaigns aimed at raising awareness about nutritional deficiency, and the broadening scope of telemedicine.
The market for iron deficiency anemia is poised to experience robust growth in the coming years. The market is estimated to reach $4.55 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.2%. Such growth during the forecast period can be ascribed to an increasing emphasis on women’s health, a rising demand for minimally invasive treatments, the accessibility of over-the-counter products, widened distribution networks, and a growing inclination towards personalized medicine. Significant trends expected in the forecasted period comprise the creation of a novel drug delivery system, advances in diagnostic instruments, progress in monitoring devices, the emergence of combination therapies, and the employment of nanotechnology within drug delivery.
How Are the key drivers Contributing to the Expansion of the Iron Deficiency Anemia Market?
The rise in instances of nutritional shortages is anticipated to boost the future prospects of the iron deficiency anemia market. Nutritional shortages denote a state in which the body doesn’t have ample amounts of one or more critical nutrients, such as vitamins, minerals, proteins, or fats, indispensable for maintaining excellent health. Due to poor food preferences, nutritional shortages are becoming increasingly prevalent, coupled with high consumption of processed foods and food insecurity, particularly among lower-income groups where access to nutrient-rich options is restricted. A typical nutritional deficiency involves iron deficiency anemia, where insufficient iron intake prompts a reduction in the number of red blood cells, thereby inhibiting the body’s oxygen transport capacity. For example, as per the data from the UK-based government department, National Health Services, in December 2023, the total hospital admissions owing to nutritional deficiency in the UK for 2021/22 were approximately 250,000, which doubled to 500,000 in 2022/23. Therefore, the escalating instances of nutritional shortages substantiate the growth of the iron deficiency anemia market.
Explore Comprehensive Insights Into The Global Iron Deficiency Anemia Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21212&type=smp
Who Are the Key Players Steering the Development of the Iron Deficiency Anemia Market?
Major companies operating in the iron deficiency anemia market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Perrigo Company, Cipla Limited, Dr. Reddy’s Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC
How Are Consumer Trends Shaping the Current and Future Landscape of the Iron Deficiency Anemia Market?
Leading entities in the iron deficiency anemia market are targeting the creation of novel methods like intravenous iron injection, aimed at offering an accurate blend of nutrients that significantly amplify absorption and improve tolerance, thus addressing iron deficiency effectively. Intravenous iron injection, a medical technique that sends iron directly to the bloodstream, is utilized to address iron deficiency or anemia in situations where oral supplements are unproductive or inadequate. For example, Cadila Pharmaceuticals, a pharmaceutical company from India, introduced Redshot FCM in March 2024. This is an intravenous iron injection composed of ferric carboxymaltose designed for effective iron deficiency anemia (IDA) treatment. The product is suited for both adults and children above one year who can’t withstand oral iron supplements. Redshot FCM provides a secure safety profile and minimal anaphylaxis risk, enabling the administration of large iron doses in one session, resulting in quick hemoglobin levels enhancement. It proves extremely useful for high-risk groups such as pregnant women, the elderly, and cancer patients.
Secure Your Global Iron Deficiency Anemia Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-global-market-report
Which Primary Segments of the Iron Deficiency Anemia Market Are Driving Growth and Industry Transformations?
The iron deficiency anemia market covered in this report is segmented –
1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion
2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies
3) By End Users: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron
2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate
3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion
Which Geographical Regions Are Shaping the Iron Deficiency Anemia Market Growth?
North America was the largest region in the iron deficiency anemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Aspects of the Iron Deficiency Anemia Market Landscape?
Iron deficiency anemia is a condition in which the body lacks enough iron to produce an adequate amount of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. Iron deficiency can occur due to insufficient dietary intake, poor absorption of iron, blood loss, or increased iron needs (such as during pregnancy).
Browse Through More Similar Reports By The Business Research Company:
Albumin Excipient Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report
Albumin Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/albumin-global-market-report
Small Cell Lung Cancer Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: